Page 118 - 《中国药房》2024年2期

（2）：305-313. [18] SHIMAMURA H，YAMADA H，OKADA N，et al. A stan‐
XIAO H L. FDA’s requirements for geriatric information dard intervention practice to promote appropriate la‐
in drug labeling and its enlightenment[J]. Drug Eval Res， motrigine therapy by pharmacists[J]. Biol Pharm Bull，
2021，44（2）：305-313. 2018，41（4）：465-469.
[ 7 ] SAHM L J，WOLF M S，CURTIS L M，et al. What’s in a [19] SAKURADA H，KAWASE Y，ASANO H，et al. Analysis
label? An exploratory study of patient-centered drug in‐ of the necessity of serum electrolyte monitoring for up to
structions[J]. Eur J Clin Pharmacol，2012，68（5）：777-782. eight weeks after the completion of anti-epidermal growth
[ 8 ] WOLF M S，DAVIS T C，CURTIS L M，et al. A patient- factor receptor antibody administration[J]. Pharmazie，
centered prescription drug label to promote appropriate 2016，71（7）：402-407.
medication use and adherence[J]. J Gen Intern Med，2016， [20] YAMAMOTO H，HABU Y，YANO I，et al. Comparison
31（12）：1482-1489. of the effects of azole antifungal agents on the anticoagu‐
[ 9 ] BAILEY S C，NAVARATNAM P，BLACK H，et al. lant activity of warfarin[J]. Biol Pharm Bull，2014，37
Advancing best practices for prescription drug labeling[J]. （12）：1990-1993.
Ann Pharmacother，2015，49（11）：1222-1236. [21] HA D，LEE S E，SONG I，et al. Comparison of signal de‐
[10] FEUFEL M A，RAUWOLF G，MEIER F C，et al. Heuris‐ tection of tumour necrosis factor- α inhibitors using the
tics for designing user-centric drug products：lessons Korea Adverse Events Reporting System Database，2005-
learned from human factors and ergonomics[J]. Br J Clin 2016[J]. Clin Rheumatol，2020，39（2）：347-355.
Pharmacol，2020，86（10）：1989-1999. [22] KADOWAKI T，INAGAKI N，WATADA H，et al. Real-
[11] BAILEY S C，PANDIT A U，YIN S，et al. Predictors of world evidence of treatment with teneligliptin/cana‐
misunderstanding pediatric liquid medication instructions gliflozin combination tablets for type 2 diabetes mellitus：
[J]. Fam Med，2009，41（10）：715-721. a post-marketing surveillance in Japan[J]. Adv Ther，
[12] MCCARTHY D M，RUSSELL A M，EIFLER M R，et al. 2022，39（4）：1642-1658.
Implementation fidelity of patient-centered prescription [23] YU H，NYSAK S，GARG N，et al. ODAE：ontology-
label to promote opioid safe use[J]. Pharmacoepidemiol based systematic representation and analysis of drug ad‐
Drug Saf，2019，28（9）：1251-1257. verse events and its usage in study of adverse events given
[13] MALHOTRA R，SUPPIAH S，TAN Y W，et al. Validation different patient age and disease conditions[J]. BMC Bio‐
of pharmaceutical pictograms among older adults with informatics，2019，20（Suppl 7）：199.
limited English proficiency[J]. Patient Educ Couns，2022， [24] SHAHABI P，SCHEINFELDT L B，LYNCH D E，et al.
105（4）：909-916. An expanded pharmacogenomics warfarin dosing table
[14] MERKS P，CAMERON J D，BALCERZAK M，et al. with utility in generalised dosing guidance[J]. Thromb
Evaluation of a pharmacist-led intervention to improve Haemost，2016，116（2）：337-348.
medication adherence in patients initiating dabigatran [25] WEINER D，POWELL J R，PATTERSON J H，et al. Le‐
treatment：a comparison with standard pharmacy practice veraging a previously published population pharmacoki‐
in Poland[J]. BMC Prim Care，2022，23（1）：210. netic model to predict rivaroxaban exposure in real-world
[15] NASUHARA Y，SAKUSHIMA K，OKI H，et al. Analysis patients[J]. J Clin Pharmacol，2022，62（12）：1518-1527.
of the implementation of blood tests specified in the packa- [26] CATTANEO D，FUSI M，COZZI V，et al. Supra-
ge insert after prescription of thiamazole[J]. J Patient Saf， therapeutic linezolid trough concentrations in elderly pa‐
2020，16（1）：24-29. tients：a call for action?[J]. Clin Pharmacokinet，2021，60
[16] CURTIS L M，MULLEN R J，RUSSELL A，et al. An effi‐ （5）：603-609.
cacy trial of an electronic health record-based strategy to [27] 范燕，夏东胜. 我国药品说明书老年人用药标示的问题
inform patients on safe medication use：the role of written 与对策[J]. 中国药物警戒，2016，13（6）：341-343，363.
and spoken communication[J]. Patient Educ Couns，2016， FAN Y，XIA D S. Problems and countermeasures of labe-
99（9）：1489-1495. ling contents of using in the elderly in medicine instruc‐
[17] WOLF M S，TAITEL M S，JIANG J Z，et al. Prevalence tions in China[J]. Chin J Pharmacovigil，2016，13（6）：341-
of universal medication schedule prescribing and links to 343，363.
adherence[J]. Am J Health Syst Pharm，2020，77（3）： （收稿日期：2023-05-25 修回日期：2023-11-28）
196-205. （编辑：孙 冰）

· 236 · China Pharmacy 2024 Vol. 35 No. 2 中国药房 2024年第35卷第2期